Interferons (IFNs) inhibit the growth of many different cell types by altering the expression of specific genes. IFNs activities are partly mediated by the 2 0 -5 0 oligoadenylates-RNase L RNA decay pathway. RNase L is an endoribonuclease requiring activation by 2 0 -5 0 oligoadenylates to cleave single-stranded RNA. Here, we present evidence that degradation of mitochondrial mRNA by RNase L leads to cytochrome c release and caspase 3 activation during IFNa-induced apoptosis. We identify and characterize the mitochondrial translation initiation factor (IF2mt) as a new partner of RNase L. Moreover, we show that specific inhibition of mitochondrial translation with chloramphenicol inhibits the IFNa-induced degradation of mitochondrial mRNA by RNase L. Finally, we demonstrate that overexpression of IF2mt in human H9 cells stabilizes mitochondrial mRNA, inhibits apoptosis induced by IFNa and partially reverses IFNa-cell growth inhibition. On the basis of our results, we propose a model describing how RNase L regulates mitochondrial mRNA stability through its interaction with IF2mt. Apoptosis is a regulated cell death process that plays a central role in the control of many physiological events. Cells die by apoptosis during embryonic development, tissue homeostasis or immune regulation and defects in the apoptotic pathway during these events can lead to excessive cell accumulation with dramatic consequences.
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Interferons (IFNs) inhibit the growth of many different cell types by altering the expression of specific genes. IFNs activities are partly mediated by the 2 0 -5 0 oligoadenylates-RNase L RNA decay pathway. RNase L is an endoribonuclease requiring activation by 2 0 -5 0 oligoadenylates to cleave single-stranded RNA. Here, we present evidence that degradation of mitochondrial mRNA by RNase L leads to cytochrome c release and caspase 3 activation during IFNa-induced apoptosis. We identify and characterize the mitochondrial translation initiation factor (IF2mt) as a new partner of RNase L. Moreover, we show that specific inhibition of mitochondrial translation with chloramphenicol inhibits the IFNa-induced degradation of mitochondrial mRNA by RNase L. Finally, we demonstrate that overexpression of IF2mt in human H9 cells stabilizes mitochondrial mRNA, inhibits apoptosis induced by IFNa and partially reverses IFNa-cell growth inhibition. On the basis of our results, we propose a model describing how RNase L regulates mitochondrial mRNA stability through its interaction with IF2mt. Cell Death and Differentiation (2007) 14, 1406-1413; doi:10.1038/sj.cdd.4402130; published online 13 April 2007 Apoptosis is a regulated cell death process that plays a central role in the control of many physiological events. Cells die by apoptosis during embryonic development, tissue homeostasis or immune regulation and defects in the apoptotic pathway during these events can lead to excessive cell accumulation with dramatic consequences. [1] [2] [3] Interferons (IFNs) are among the regulators of apoptosis. They belong to a family of cytokines produced and secreted by mammalian cells in response to various inducers. They are negative regulators of cell proliferation through induction of cell-cycle arrest and apoptosis, but the mechanisms are not yet fully understood. The 2-5A/RNase L pathway is a single-stranded RNA (ssRNA) decay pathway induced by IFNs: the 2-5A synthetases are induced by IFNs and upon activation by doublestranded RNA (dsRNA), convert ATP into a series of oligomers known as 2 0 -5 0 oligoadenylates (2-5A). 4, 5 The 2-5A activates RNase L, a latent endoribonuclease, which inhibits protein synthesis by cleaving ssRNA. 6, 7 RNase L plays a central role in IFNs cell growth inhibition and in IFN-induced apoptosis. [8] [9] [10] [11] [12] Activation of RNase L causes caspase-dependent apoptosis accompanied by cytochrome c release from the mitochondria. [13] [14] [15] Moreover, we have shown that part of RNase L is localized in mitochondria and regulates mitochondrial mRNA stability in IFNa-treated cells. 12 RNase L is an endoribonuclease which has little sequence specificity as it cleaves RNA 3 0 of UpNp nucleotides. 6, 7 On the other hand, only a few cellular RNAs have been identified as regulated by RNase L: rRNA, 16 IFN-induced genes ISG43 and ISG15 mRNAs, 17 mitochondrial mRNAs, 12, 18 MyoD mRNA during C2 myoblast differentiation 19 and PKR mRNA. 20 RNase L activity is regulated not only by 2-5A binding, but also by interaction with other proteins. It has been shown previously that RNase L can form a heterodimer with the RNase L inhibitor (RLI), a protein that inhibits 2-5A binding to RNase L, resulting in an inhibition of RNase L activity. 21, 22 More recently, we demonstrated that RNase L interacts with the translation termination release factor eRF3/GSPT1 and that their interaction is important for its role in translation termination regulation. 23 We set out to identify other potential RNase L partners to better comprehend its mechanism of action. In the present study, a yeast two-hybrid screening, using human RNase L as bait identifies the mitochondrial initiation factor IF2mt as a partner of RNase L. We demonstrate that RNase L interacts with IF2mt in vitro and that this interaction modulates mitochondrial mRNAs stability in vivo. Moreover, overexpression of IF2mt abrogates mitochondrial RNase L activity, inhibits IFNa-induced apoptosis and partially reverses antiproliferative activity of IFNa. These results outline a new mechanism for RNase L as a regulator of mitochondrial mRNA stability through its recruitment to mRNA during their translation via its interaction with IF2mt.
Results
RNase L interacts with IF2mt. To identify potential RNase L partners and better understand its mechanism of action, we performed a yeast two-hybrid screening using the human RNase L as bait and a human HeLa S3 cDNA library as a prey. One of the positive clones was identified by sequence analysis as the mitochondrial translation initiation factor 2 (IF2mt). 24 IF2mt promotes the binding of fMet-tRNA to the small subunit of mitochondrial ribosomes. 25 IF2mt is encoded by a precursor of 90 kDa, which, following its import in the mitochondria, is cleaved to give rise to an 85 kDa mature protein. The identification of IF2mt as a partner of RNase L is consistent with the previously observed mitochondrial localization of RNase L in H9 and HeLa cells. 12 We confirmed the interaction between RNase L and IF2mt by pull-down and co-immunoprecipitation assays. For the pulldown assay, RNase L was tagged with GST in the C terminus and IF2mt was translated in the presence of radioactive methionine in rabbit reticulocyte lysate (RRL). The recombinant proteins, RNase L-GST or GST, were bound to glutathione-sepharose and mixed with RRL containing the radiolabeled IF2mt. The resulting bound and unbound proteins to glutathione-sepharose were analyzed by SDS-PAGE ( Figure 1a ) and the radiolabeled IF2mt associated with the beads was quantified (Figure 1b Decrease of mitochondrial mRNA stability by IFNa2 is translation dependent. As IF2mt is a mitochondrial translation initiation factor and RNase L has been shown previously to regulate mitochondrial mRNA stability, 12 we tested whether an active translation was required for the destabilization of mitochondrial mRNA by IFNa-activated RNase L. To address this question, we measured mitochondrial mRNA level in H9 cells treated with IFNa2 and/or chloramphenicol (CAM) to inhibit mitochondrial translation (Figure 2) . 26 The H9 . 27 These results demonstrate that inhibition of mitochondrial translation To confirm that the mitochondrial mRNA decrease observed during the IFNa2 treatment (Figure 2a ) is due to mRNA decay, we compared their stability following actinomycin D chase (Figure 2b) . 26 We observe a destabilization of mitochondrial mRNAs CYTb, ATP6 and COII when H9 cells are treated with IFNa2 ( Figure 2b , compare IFNa2 with Control). On the contrary, we observe a stabilization of mitochondrial mRNAs in H9 cells treated with IFNa2 and chloramphenicol compared to the cells treated with IFNa2 alone (Figure 2b ). These results suggest that RNase L regulates mitochondrial mRNA stability in a translationdependent manner.
RNase L/IF2mt interaction modulates RNase L activity. To confirm the role of the RNase L/IF2mt interaction in the translation-dependent decay of mitochondrial mRNAs, we overexpressed IF2mt in H9 cells. We hypothesized that an excess level of IF2mt protein will trap RNase L away from the mitochondrial translation initiation complex and will inhibit mitochondrial mRNA degradation. We stably transfected H9 cells with a plasmid encoding IF2mt. As no antibody against human IF2mt is available, we selected the clone expressing the highest level of . 12 These results show that overexpression of IF2mt blocks RNase L nuclease activity induced by IFNa2 in mitochondria.
We have shown previously that the downregulation of the mitochondrial mRNAs by RNase L is observed during the antiproliferative effect of IFNa2. 12 To study the role of the RNase L/IF2mt interaction in the antiproliferative effect of IFNa2, we measure the growth rate of H9 cells overexpressing IF2mt (IF2mt2 clone). We observe an 80% inhibition of control IFNa-induced apoptosis is associated with cytochrome c release in the cytoplasm and caspase 3 activation. 28, 29 RNase L plays an important role in IFNa-induced apoptosis 9, 10 and its activation causes caspase-dependent apoptosis accompanied by cytochrome c release from the mitochondria. [13] [14] [15] To investigate the role of the RNase L/IF2mt interaction in IFNa-induced apoptosis, we measured cytochrome c release, caspase 3 cleavage and its activity in Figure 6b ). These results demonstrate that overexpression of IF2mt can modulate IFNa-induced apoptosis in H9 cells by blocking the cytochrome c release from mitochondria and by inhibiting the caspase 3 cleavage and activity. Therefore, the RNase L/IF2mt interaction mediates RNase L mitochondrial nuclease activity, modulates mitochondrial IFNa-induced apoptosis and partially regulates the IFNa antiproliferative activity.
Discussion
In this report, we show that IF2mt interacts with RNase L. In addition, we provide evidence that IF2mt/RNase L interaction is important for mitochondrial mRNA degradation by RNase L and apoptosis induced by IFNa.
IF2mt interacts with RNase L
Earlier observations showed that RNase L activity is regulated by its interaction with other proteins like RLI and eRF3/ GSPT1. 21, 23, 30 To discover new pathways of RNase L regulation and new partners, we performed a yeast twohybrid screening using the human RNase L as bait and RNase L mitochondrial mRNA decay is translation dependent. The identification of IF2mt as a partner of RNase L raises the question of the biological importance of this interaction. IF2mt is a mitochondrial translation initiation factor, whereas RNase L regulates the mitochondrial mRNAs stability. 12, 18 Thus, one potential role for IF2mt is to help localizing RNase L to its mRNA target during translation initiation. This possibility was supported by the finding that inhibition of mitochondrial translation by chloramphenicol blocks mitochondrial mRNA decay induced by IFNa2 (Figure 2 ). This report shows that RNase L regulation of mitochondrial mRNAs is dependent on translation.
RNase L/IF2mt interaction regulates RNase L activity in mitochondria. To examine in more depth the hypothesis that RNase L can regulate mitochondrial mRNA decay through its interaction with IF2mt, we extended the study to cells overexpressing IF2mt (Figures 3-6 ). We hypothesized that overexpression of IF2mt in cells increases the amount of IF2mt factor available in the mitochondria and titrates RNase L from the mitochondrial translation initiation complex. We found that overexpression of IF2mt in H9 cells blocks mitochondrial mRNAs degradation induced by IFNa2 (Figure 4 ). This complete stabilization of mitochondrial mRNAs was similar to the stabilization level observed by overexpressing the RLI or an RNase L antisense (Figure 4) . 12 Interestingly, the inhibition of RNase L nuclease activity in mitochondria (Figure 4 ) blocks mitochondrial apoptosis induced by IFNa2 (Figure 6 ). These results highlight for the first time that degradation of mitochondrial mRNA by RNase L plays a role in mitochondria-dependent apoptosis induced by IFNa2. We propose that the degradation of mitochondrial mRNAs by RNase L will lead to inhibition of mitochondrial protein synthesis. The consequence of such an inhibition will be a loss of mitochondrial membrane potential which results in osmotic swelling and cytochrome c release 31 accompanied by caspase-3 cleavage. Taken together, our results show that RNase L/IF2mt interaction mediates RNase L mitochondrial nuclease activity, and consequently, the mitochondrial IFNa-induced apoptosis.
The inhibition of mitochondrial RNase L nuclease activity by IF2mt overexpression reverses IFNa-induced apoptosis and only partially IFNa cell-growth inhibition (compare Figures 5a  and 6a ). On the contrary, when the cytoplasmic and mitochondrial RNase L activities are inhibited by expression of RNase L antisense, IFNa treatment does not affect cell proliferation (compare Figure 5a and 5b) . 12 The difference observed could be explained by the existence of nuclearencoded mRNAs regulated by RNase L involved in growth inhibition induced by IFNa2, like PKR or antizymes mRNAs. 20, 23 Moreover, these results suggest that only the IFNa-induced apoptosis is inhibited in IF2mt2 cells and IFNa could go on to exert its cell-growth inhibition, via other mechanisms than mitochondrial apoptosis. IFNa affect cell proliferation by two mechanisms: apoptosis and cell-growth inhibition. 32 The degradation of mitochondrial mRNA by RNase L seems to be an essential mechanism for the mitochondrial IFNa-induced apoptosis, but less important for the mechanism of cell-growth inhibition of IFNa. This indicates the partial interplay between these two mechanisms.
Cells vary in their sensitivity to IFNa treatment, but the reasons of this difference are not completely understood. This difference in cell sensitivity to IFNa treatment could be due to a defect in one or both of these two mechanisms: apoptosis and cell-growth inhibition.
Model for the mechanism of RNase L regulation of mitochondrial mRNA stability. Previous studies indicate that IF2mt plays a key role in mitochondrial translation initiation (Figure 7a) . 33 Mitochondrial mRNA binds to the 28S subunit, which is positioned randomly on the RNA. The mitochondrial translational initiation factor 3 (IF3mt) is postulated to alter the position of the mRNA, promoting the positioning of the 5 0 start codon into the P-site. Following the correct positioning of the mRNA, IF2mt promotes the binding of fMet-tRNA. Finally, the 39S subunit joins this complex, which leads to the release of the initiation factors and the formation of the 55S initiation complex (Figure 7a ). Based on our findings, we propose the following model describing the RNase L degradation of mitochondrial mRNA (Figure 7b) . The IF2mt-RNase L interaction brings RNase L into close association with the mitochondrial mRNA before the assembly of the 55S initiation complex and the release of the initiation factors IF2mt and IF3mt. As the IF2mt-RNase L interaction does not require 2-5A, RNase L could be recruited to the mitochondrial mRNAs as a latent endoribonuclease. IFNa treatment induces 2-5A synthesis, which leads to RNase L activation, mitochondrial mRNA degradation and apoptosis mediated by cytochrome c release and caspase 3 cleavage (Figure 7b ). In cells overexpressing IF2mt, our data suggest that an excess level of IF2mt protein traps RNase L away from the mitochondrial translation initiation complex. This causes inhibition of mitochondrial mRNA degradation and apoptosis induced by IFNa (Figure 7c ).
Materials and methods
Yeast two-hybrid screening. Yeast two-hybrid screening was carried out using the L40 yeast strain (MATa, trp1, leu2, his3, LYS2HlexA-His3, URA3HlexA-LacZ) harboring HIS3 and -gal reporter genes under the control of upstream LexA DNA-binding site as originally described. 34 The bait consisted of the human RNase L open reading frame fused to LexA DNA-binding domain (pBTM116-RNase L). About 350 000 clones of a HeLa cell cDNA library (Clontech, Mountain view, CA, USA) constructed in the GAL4 activation domain vector pGADGH were screened for their interaction with RNase L. The plasmids isolated from positive colonies were amplified on a large scale and the nucleotide sequences were determined using an automat sequencer and analyzed using the BLAST algorithm on EMBL and GenBank database.
Cells. Human H9 lymphocytes (lymphoma, cutoneous T lymphocyte ATCC HTB-176) were grown in RPMI 1640 medium (Gibco-BRL, Gaithersburg, MD, USA) supplemented with 10% (v/v) fetal calf serum (Gibco-BRL). Cells were incubated at 371C in a 5% CO2, 95% air atmosphere. For cell growth experiments, 10 3 cells/well were seeded in 24-well plates (day 0) and IFNa (500 U/ml) was added on the cells, which must be treated with IFNa after 24 h (day 1). The viable cells were counted on day 1, just before adding IFNa, and each following day during a period of 6 days. Cell growth was determined by counting viable cells as determined by trypan blue exclusion.
Cell extracts. H9 cells were washed twice in ice-cold phosphate-buffered saline (PBS: 140 mM NaCl, 2 mM KCl, 8 mM Na 2 HPO 4 (pH 7.4)), pelleted, resuspended in 2 volumes of hypotonic buffer (0.5% (v/v) Nonidet P-40 (NP-40), 20 mM HEPES (pH 7.5), 10 mM KOAc, 15 mM Mg(OAc)2, 1 mM phenyl methyl sulfonyl fluoride (PMSF), 10 mg/ml aprotinin, 150 mg/ml leupeptin), incubated 10 min on ice, disrupted with a Dounce homogenizer and centrifuged 10 min at 10 000 Â g. The protein concentration was determined by Bradford reaction. 35 Expression vectors and transfection. The coding sequences of human IF2mt cDNA 24 were subcloned in pcDNA3neo (Invitrogen, Carlsbad, CA, USA) by standard procedures. 36 Transfected H9 cell clones were isolated by dilution of 1 cell/ slot in 96-slot plates in the presence of 1 mg/ml Geneticin (Gibco-BRL). IF2mt has a peptide leader at its NH 2 extremity which is necessary for its mitochondrial localization and its COOH extremity allows its interaction with the ribosome. 25 For these reasons, we stably transfected H9 cells with the coding sequence of untagged IF2mt to avoid a decreased IF2mt activity due to a competition between cellular IF2mt and a less active or inactive IF2mt. IF2mt activity might be critical for the cell, as we could not obtain H9 cells stably transfected with IF2mt antisense construct. Two clones expressing sense IF2mt cDNA were selected and named: IF2mt1 and IF2mt2. An empty pcDNA3 vector-transfected clone was used as a control.
RNA analysis. IF2mt1, IF2mt2 and control cells were plated at 2.0 Â 10 5 cells/ ml, treated for 24 or 48 h by human IFNa2 (500 U/ml) or IFNa2 and chloramphenicol (50 mg/ml) and collected for RNA extraction using the guanidine thiocyanate-lithium chloride procedure. 37 Total RNAs (20 mg) were analyzed by Northern blot. 36 After transfer onto nylon membranes (Appligen, Illkirch, Graffenstaden, France), rRNA were revealed with 0.5 M Na acetate (pH 5), 0.04% (w/v) methylene blue. The nylon membranes were then incubated with the appropriate [ 32 P]cDNA probes (as indicated in the figure legends) synthesized using the Multiprime radiolabeling kit (Gibco-BRL) and autoradiographied on a PhosphoImager 445-SI (Molecular Dynamics, Sunnyvale, CA, USA).
To determine the stability of mitochondrial mRNAs (ATP6, CYTB, COII), H9 cells were treated with or without IFNa2 (500 U/ml during 24 h) and chloramphenicol (50 mg/ml) and then with actinomycin D (5 mg/ml). Total RNA were isolated at increasing time points after treatment and were analyzed by Northern blot as described above.
Gene expression was detected by RT-PCR using the SuperScript First-strand Synthesis System for RT-PCR (InVitrogen). Briefly, 3 mg of total RNA was denatured at 701C and then reverse-transcribed by RT enzyme at 421C for 50 min. Target gene expression was detected by PCR amplification by using following specific primer pairs: sense 5 0 for OAS2. PCR was performed with 30 cycles in 25 ml of reaction mixture, after 2 min at 941C cycling conditions were: 30 s at 941C, 30 s at 581C, 30 s at 721C then 7 min at 721C. PCR products were visualized in 2% agarose gels stained with ethidium bromide. The experiments were done in triplicate, and the standard deviation is indicated on the plots.
Pull-down experiments. Recombinant RNase L tagged with glutathione Stransferase (GST), produced in baculovirus-infected insect cells 38 was incubated 1 h at room temperature with glutathione-sepharose (Amersham Biosciences, Piscataway, NJ, USA) equilibrated in Tris buffer (10 mM Tris-HCl (pH 7.5), 130 mM NaCl, 1 mM PMSF, 10 mg/ml aprotinin, 150 mg/ml leupeptin). After washing three times with Tris buffer supplemented with 0.1% (v/v) NP-40 and 0.2% (w/v) bovine serum albumin, glutathione-sepharose was incubated with rabbit reticulocyte extract (45 ml), for 1 h at room temperature where human IF2mt was translated in presence of 35 S-methionine according to manufacturer protocol (Promega, Madison, WI, USA). The mix was centrifuged and the supernatant was considered as the unbound proteins fraction. The glutathione-sepharose was then washed five times with Tris buffer supplemented with 0.1% (v/v) NP-40 and resuspended in 50 ml of gel analysis buffer: 60 mM Tris-HCl (pH 6.8), 2% (w/v) sodium dodecyl sulfate (SDS), 100 mM dithiothreitol (DTT), 5% (v/v) b-mercaptoethanol, 0.001% (w/v) bromophenol blue, 10% (v/v) glycerol, heated at 951C during 10 min, pelleted at 10 000 Â g during 2 min. The supernatant was considered as the bound proteins fraction and analyzed by 10% (v/v) SDS-PAGE. 39 Labeled proteins were visualized after autoradiography (PhosphorImager) and proteins bands were quantified by image analysis with the Intelligent Quantifier program (BioImage systems corporation, Jackson, MI, USA).
Co-immunoprecipitation experiments. Human IF2mt was translated in rabbit reticulocyte extract (45 ml) in the presence of 35 S-methionine according to manufacturer protocol (Promega). After translation, the reaction was incubated 3 h at room temperature under gentle shaking, with polyclonal antibodies against RNase L (80 mg/ml) 38 or with the irrelevant antibody anti-lexA (1/5001) (a generous gift of Didier Fesquet, CRBM, Montpellier, France) in 450 ml of immunoprecipitation buffer (10 mM Tris-HCL (pH 7.5), 130 mM NaCl, 0.1% NP-40, 1 mM PMSF, 10 mg/ml aprotinin, 150 mg/ml leupeptin). After addition of protein A-sepharose (Amersham Biosciences), the reaction was incubated overnight at 41C with gentle shaking. After several washes with the immunoprecipitation buffer, the protein Asepharose was resuspended in gel analysis buffer, heated at 951C for 10 min, pelleted at 10 000 Â g for 2 min. The supernatant was analyzed by 10% (v/v) SDS-PAGE and exposure to PhosphorImager.
Western blot analysis. Cytoplasmic extracts (200 mg proteins) were analyzed by 10% (v/v) SDS-PAGE. 39 Proteins were then transferred on a nitrocellulose sheet, 40 blocked in PBS supplemented with 5% (w/v) non-fat milk and then soaked overnight at 41C with one of the different specific antibodies: rabbit polyclonal antibody against caspase 3 (1/5001) (Cell Signaling Technology, Danvers, MA, USA), mouse monoclonal antibody against RNase L (1 mg/ml) and rabbit polyclonal antibody against RLI (0.4 mg/ml) (Abcam, Cambridge, UK), rabbit polyclonal antibody against cytochrome c (0.2 mg/ml) (Santa-Cruz Biotechnology,
